|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM203609999 |
003 |
DE-627 |
005 |
20231223230441.0 |
007 |
cr uuu---uuuuu |
008 |
231223s2011 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.clim.2010.10.003
|2 doi
|
028 |
5 |
2 |
|a pubmed24n0679.xml
|
035 |
|
|
|a (DE-627)NLM203609999
|
035 |
|
|
|a (NLM)21075690
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Lundell, Anna-Carin
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Development of gut-homing receptors on circulating B cells during infancy
|
264 |
|
1 |
|c 2011
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 08.03.2011
|
500 |
|
|
|a Date Revised 16.11.2017
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Copyright © 2010 Elsevier Inc. All rights reserved.
|
520 |
|
|
|a B cell gut-homing is mainly mediated by α4β7, CCR9 and CCR10. We here studied the expression of these receptors on B cells from cord blood and from peripheral blood at 1, 4, 18 and 36 months of age in a prospective cohort of Swedish infants. The proportion of all B cells expressing α4β7 as well as the fraction of CCR10+ B cells expressing α4β7 was highest in early infancy. Nearly all naïve B cells in all age groups expressed α4β7, whereas the expression on class-switched B cells decreased with age. Moreover, the proportion of both IgA+ and IgG+ B cells expressing α4β7, CCR9 and CCR10 were higher during the first months when compared to adults. In conclusion, the high fraction of circulating IgA+ and IgG+ B cells expressing CCR9 and CCR10 in the first months of life indicates activation of naïve B cells in the gut, coinciding with bacterial colonization
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
7 |
|a CC chemokine receptor 9
|2 NLM
|
650 |
|
7 |
|a CCR10 protein, human
|2 NLM
|
650 |
|
7 |
|a Immunoglobulin A
|2 NLM
|
650 |
|
7 |
|a Immunoglobulin G
|2 NLM
|
650 |
|
7 |
|a Integrins
|2 NLM
|
650 |
|
7 |
|a Receptors, CCR
|2 NLM
|
650 |
|
7 |
|a Receptors, CCR10
|2 NLM
|
650 |
|
7 |
|a Receptors, Lymphocyte Homing
|2 NLM
|
650 |
|
7 |
|a Tumor Necrosis Factor Receptor Superfamily, Member 7
|2 NLM
|
650 |
|
7 |
|a integrin alpha4beta7
|2 NLM
|
700 |
1 |
|
|a Rabe, Hardis
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Quiding-Järbrink, Marianne
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Andersson, Kerstin
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Nordström, Inger
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Adlerberth, Ingegerd
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Wold, Agnes E
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Rudin, Anna
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 138(2011), 1 vom: 15. Jan., Seite 97-106
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
773 |
1 |
8 |
|g volume:138
|g year:2011
|g number:1
|g day:15
|g month:01
|g pages:97-106
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2010.10.003
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 138
|j 2011
|e 1
|b 15
|c 01
|h 97-106
|